Capital Flow Monitor · Sponsors · CIK 2095970

Blackstone Life Sciences VI - B L.P.

345 PARK AVENUE, NEW YORK, NY, 10154 · 212-583-5000

Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2025

Fit score

—

Offering

$6.3B

Sold

$6.3B

% sold

100.0%

Investors

1

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-04-02 D/A ·current 506(b) $6.3B $6.3B 100.0% 1 EDGAR ↗
2025-11-20 D 506(b) — $3.62B — 1 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.